Trial Profile
A Phase II, Multi-Center, Double-Masked, Randomized, Placebo Controlled, Study on the Safety and Efficacy of RX-10045 on the Signs and Symptoms of Dry Eye in Every Day Environmental Conditions and During Provocation Using the Controlled Adverse Environment (CAE) Model
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2014
Price :
$35
*
At a glance
- Drugs RX 10045 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Resolvyx Pharmaceuticals
- 12 May 2014 New trial record